HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Hee Kang Selected Research

Young-Hee Kang Research Topics

Disease

21Inflammation (Inflammations)
04/2021 - 02/2007
17Neoplasms (Cancer)
05/2017 - 12/2004
15Atherosclerosis
11/2021 - 08/2002
15Fibrosis (Cirrhosis)
11/2020 - 03/2010
9Bone Resorption
06/2021 - 01/2012
8Hyperglycemia
11/2020 - 10/2008
7Asthma (Bronchial Asthma)
07/2018 - 01/2012
7Hyperplasia
12/2017 - 01/2009
6Hypoxia (Hypoxemia)
11/2020 - 01/2013
5Osteoporosis
11/2021 - 08/2012
5Insulin Resistance
06/2021 - 12/2010
5Obesity
08/2016 - 12/2010
4Thrombosis (Thrombus)
04/2021 - 06/2010
4Diabetic Nephropathies (Diabetic Nephropathy)
11/2020 - 03/2010
4Neoplasm Metastasis (Metastasis)
05/2017 - 01/2009
4Diabetes Complications
02/2015 - 04/2008
4Edema (Dropsy)
11/2014 - 05/2013
3Emphysema
04/2021 - 02/2017
3Proteinuria
11/2019 - 08/2017
3Body Weight (Weight, Body)
10/2018 - 02/2015
3Prostatic Neoplasms (Prostate Cancer)
01/2016 - 01/2013
3Leukemia
12/2015 - 01/2007
3Breast Neoplasms (Breast Cancer)
11/2015 - 10/2009
3Carcinogenesis
06/2014 - 08/2009
3Colonic Neoplasms (Colon Cancer)
06/2014 - 01/2002
3Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2008 - 12/2004
2Postmenopausal Osteoporosis
06/2022 - 09/2014
2Atrophy
06/2022 - 09/2014
2Type 2 Diabetes Mellitus (MODY)
06/2021 - 08/2016
2Pneumonia (Pneumonitis)
03/2021 - 07/2018
2Eosinophilia
12/2017 - 07/2014
2Melanoma (Melanoma, Malignant)
05/2017 - 07/2014
2Hypersensitivity (Allergy)
12/2015 - 05/2013
2Lung Diseases (Lung Disease)
04/2015 - 01/2015
2Metabolic Diseases (Metabolic Disease)
01/2014 - 12/2010

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
04/2021 - 10/2008
11Glucose (Dextrose)FDA LinkGeneric
11/2020 - 03/2010
8CytokinesIBA
08/2020 - 06/2010
7Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021 - 12/2004
6AntioxidantsIBA
06/2021 - 08/2002
6OvalbuminIBA
09/2019 - 01/2013
6LipidsIBA
10/2018 - 01/2010
5FlavonoidsIBA
04/2021 - 05/2005
5EndotoxinsIBA
12/2017 - 01/2012
5kaempferolIBA
12/2015 - 01/2012
5oxidized low density lipoproteinIBA
10/2012 - 08/2002
4esculetinIBA
11/2021 - 08/2020
4astragalinIBA
04/2021 - 07/2014
4IntegrinsIBA
12/2020 - 08/2012
4chrysinIBA
07/2018 - 07/2015
4PhloretinIBA
11/2017 - 08/2012
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2015 - 01/2012
4AdipokinesIBA
02/2013 - 12/2010
4Arsenic Trioxide (Trisenox)FDA Link
10/2008 - 12/2004
3Estrogens (Estrogen)FDA Link
06/2022 - 01/2013
3SmokeIBA
04/2021 - 07/2018
3Interleukin-8 (Interleukin 8)IBA
08/2020 - 12/2012
3Cathepsin KIBA
01/2020 - 01/2012
3EucalyptolIBA
11/2019 - 12/2017
3CateninsIBA
12/2017 - 10/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 01/2013
3Platelet Endothelial Cell Adhesion Molecule-1IBA
12/2016 - 06/2005
3Anthocyanins (Anthocyanin)IBA
02/2015 - 06/2009
3ResveratrolIBA
01/2015 - 01/2007
3Messenger RNA (mRNA)IBA
01/2015 - 12/2010
3LigandsIBA
09/2014 - 08/2012
3Oleanolic AcidIBA
03/2014 - 12/2010
3CollagenIBA
03/2014 - 04/2012
3ResistinIBA
02/2013 - 12/2010
3Ellagic AcidIBA
11/2011 - 04/2008
3p38 Mitogen-Activated Protein KinasesIBA
10/2008 - 01/2007
2coumarinIBA
11/2021 - 01/2020
22,4,5-trimethoxybenzoic acidIBA
11/2021 - 07/2020
2TeaIBA
04/2021 - 04/2015
2Tartrate-Resistant Acid PhosphataseIBA
01/2020 - 01/2012
2Advanced Glycation End ProductsIBA
01/2019 - 07/2018
2Blood Glucose (Blood Sugar)IBA
10/2018 - 02/2015
2Insulin (Novolin)FDA Link
10/2018 - 08/2016
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2018 - 11/2014
2oleuropeinIBA
07/2018 - 05/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 04/2011
2cadherin 5IBA
05/2017 - 12/2016
2benzyl isothiocyanateIBA
01/2016 - 01/2015
2Bovine Serum AlbuminIBA
12/2015 - 10/2008
2Caspase 3 (Caspase-3)IBA
11/2015 - 06/2013
2CholesterolIBA
04/2015 - 11/2011
2AntigensIBA
01/2015 - 05/2013
2LipopolysaccharidesIBA
11/2014 - 05/2013
2Nicotinamide PhosphoribosyltransferaseIBA
03/2014 - 12/2010
2QuercetinIBA
10/2013 - 03/2007
2Biological ProductsIBA
10/2013 - 07/2010
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2013 - 05/2013
2licochalcone EIBA
06/2013 - 05/2013
2Silybin (Lagosa)IBA
01/2013 - 01/2012
2Aldehyde Reductase (Aldose Reductase)IBA
01/2013 - 04/2008
2Connective Tissue Growth FactorIBA
12/2012 - 04/2012
2LDL Lipoproteins (beta Lipoproteins)IBA
10/2012 - 08/2002

Therapy/Procedure

8Oral Administration
10/2018 - 03/2014
4Therapeutics
12/2020 - 01/2007
2Complementary Therapies (Alternative Medicine)
06/2022 - 04/2021